600 patients66,869 observations120 daysLIVE

Patient P-01776

Synthetic patientNBL-101 · Day 119 · 75+ · F · baseline S16Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Improving
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
93%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S16
  2. Day 31 NP-02 recommendedDietary Support Protocol NP-02
  3. Day 32 Patient acceptedStarted NP-02 in the companion
  4. Day 42 No meaningful changeDietary Support Protocol NP-02
  5. Day 47 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 47.

Primary contributors, last 14 days
  • Nutritional resilience-6
  • Toxicity-5
  • GI instability+3
  • Inflammatory activity-3

What helped?

  • Dietary Support Protocol NP-02Day 31
    Result: no meaningful change
LIFE OS recommendation
GI Support Protocol GI-04
87%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 83% showed improvement
  • median effect visible after 8 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
67.3/100
worsening · +3.6 vs previous 14 d
Toxicity
Blood
57.4/100
improving · -7.1 vs previous 14 d
Sleep quality
Wearable
12.6/100
improving · +1.7 vs previous 14 d
Energy level
Daily log
1.8/10
improving · +0.1 vs previous 14 d
Stress level
Daily log
8/10
stable · -0.0 vs previous 14 d
Steps
Wearable
5,950
stable · -59 vs previous 14 d
Adherence
Companion
40.5 %
worsening · -1.9 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 24 from the failing basin, 71 from restoration.

Would help
  • GI-04 GI Support Protocol
    73% improved among 124 similar · onset 8 d · confidence 90%
  • ME-01 Monitoring Escalation
    100% improved among 77 similar · onset 3 d · confidence 71%
  • SC-12 Supportive Compound
    76% improved among 51 similar · onset 6 d · confidence 71%
Would not help
  • NP-02 Dietary Support Protocol
    already tried, no meaningful change
  • Keep fat low
    GI +7.4 next day on high-intake days · n 28
  • Keep simple carbs low
    GI +4.7 next day on high-intake days · n 22
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +7.4detractor · 95%
  • Simple carbohydrates
    +4.7detractor · 95%
  • Histamine load
    -0.3no signal · 15%
  • Alcohol
    -0.3no signal · 15%
  • Insoluble fibre
    -0.2no signal · 15%
  • Spicy / capsaicin
    +0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 60
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 63
    • WearableHRV 15 ms, trending down
  • Butyrate / short-chain fatty acid production 55
    • MicrobiomeButyrate capacity 27/100
    • Daily logFibre intake low in recent food logs
  • Mucosal barrier integrity 30
    • Daily logGI symptom score 67 and rising
    • WearableSleep 5.4 h, below personal baseline
  • Drug metabolism and exposure 20
    • BloodToxicity index 57
  • Autonomic recovery 20
    • WearableShort sleep window
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Normal metabolizer
    Expected exposure
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 2.9 · butyrate capacity 27/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
16 ms
Sleep
5.2 h
Steps
5,940
Resting HR
70 bpm
Daily log: GI score 67, nutritional resilience 31, adherence 41.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • Keep the current walking rhythm
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0180417%S19AD-05improved61
P-0137716%S11AD-05no change42
P-0135016%S19BR-03no change34
P-0170826%S07CR-01improved59
P-0169624%S20CR-01improved59
P-0183524%S17CR-01improved56
P-0187724%S01CR-01improved67
P-0138823%S17CR-01improved59
P-0137122%S06CR-01improved63
P-0144221%S13CR-01improved61
P-0143017%S05CR-01improved54
P-0134216%S11DT-01improved48